share_log

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collins Helen Louise

SEC ·  Oct 23 04:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more